Södertälje, Sweden

Xiufeng Xu

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiufeng Xu. Retrieved from https://idiyas.com/inventor/xiufeng-xu-kv9lchjb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiufeng Xu - Innovator in Cell Genome Modification

Introduction

Xiufeng Xu is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of cell genome modification. With a total of 2 patents to his name, Xu is recognized for his innovative approaches and methodologies.

Latest Patents

One of his latest patents is titled "Inducible Modification of a Cell Genome." This patent focuses on compositions and methods for the inducible modification of a cell genome. The work aims to enhance the precision and efficiency of genetic modifications, which can have profound implications in various fields, including medicine and agriculture.

Career Highlights

Xiufeng Xu is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Among his coworkers are Himjyot Jaiswal and Lorenz M. Mayr, who are also involved in innovative research initiatives. Their collaboration fosters a dynamic environment for scientific discovery and advancement.

Conclusion

In summary, Xiufeng Xu is a prominent inventor whose work in cell genome modification is paving the way for future innovations in biotechnology. His contributions are essential for advancing our understanding and capabilities in genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…